Lung cancer (LC) represents a problem of high magnitude for the medical systems due to its morbidity and mortality, also because of the huge human and economical efforts and costs that it catalyzes.Only in Europe, the average life-time cost of lung cancer patients ranges between €46,000 and €61,000 per patient.